# the Safety and Efficacy of Intravitreal Injection of Tpdelansbsalbac in Malignant Effusions.

> **NCT06178003** · NA · UNKNOWN · sponsor: **The First Affiliated Hospital of Xinxiang Medical College** · enrollment: 65 (estimated)

## Conditions studied

- Salmonella Bacteremia

## Interventions

- **BIOLOGICAL:** Tpdelansbsalbac

## Key facts

- **NCT ID:** NCT06178003
- **Lead sponsor:** The First Affiliated Hospital of Xinxiang Medical College
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-11
- **Primary completion:** 2024-04-01
- **Final completion:** 2025-01-01
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2024-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06178003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06178003, "the Safety and Efficacy of Intravitreal Injection of Tpdelansbsalbac in Malignant Effusions.". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06178003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*